Cointime

Galleon Pharmaceuticals

company

About

Galleon Pharmaceuticals is engaged in the discovery and development of medicines for breathing-control conditions in the United States.

  • 11 - 50

Highlights

Total Funding Amount
$10M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$10M
Industries
Biotechnology,Life Science,Pharmaceutical
Founded date
Jan 1, 2003
Number Of Employee
11 - 50
Operating Status
Active

Galleon Pharmaceuticals engages in the discovery and development of medicines for breathing-control conditions in the United States. It focuses on developing a portfolio of therapeutics for the treatment of sleep apnea, ventilator weaning, anesthetic/analgesic-induced respiratory depression, COPD, obesity-hypoventilation syndrome, and other common diseases. The company was incorporated in 2003 and is based in Horsham, Pennsylvania.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$10M
Galleon Pharmaceuticals has raised a total of $10M in funding over 2 rounds. Their latest funding was raised on Jun 11, 2015 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 11, 2015 Series B $10M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Galleon Pharmaceuticals is funded by 1 investors. TPG are the most recent investors.
Investor Name Lead Investor Funding Round
TPG — Series B
Cointime
เนื้อหา
บริษัท